Back to Journals » Therapeutics and Clinical Risk Management » Volume 9

Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations
Total article views | Abstract views | HTML views | PDF downloads | Totals | |
---|---|---|---|---|---|
7,575 | Dovepress* | 5,958 | 529+ | 1,839 | 6,487 |
PubMed Central* | 0 | 1,088 | 313 | 1,088 | |
Totals | 5,958 | 1,617 | 2,152 | 7,575 | |
*Since 25 November 2013 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
6 | 0 | 0 | 0 | 3 | 3 |
View citations on PubMed Central and Google Scholar